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Immunological memory in vertebrates is often exclu-
sively attributed to T and B cell function. Recently it
was proposed that the enhanced and sustained
innate immune responses following initial infectious
exposure may also afford protection against reinfec-
tion. Testing this concept of ‘‘trained immunity,’’
we show that mice lacking functional T and B
lymphocytes are protected against reinfection with
Candida albicans in a monocyte-dependent manner.
C. albicans and fungal cell wall b-glucans induced
functional reprogramming of monocytes, leading to
enhanced cytokine production in vivo and in vitro.
The training required the b-glucan receptor dectin-
1 and the noncanonical Raf-1 pathway. Monocyte
training by b-glucans was associated with stable
changes in histone trimethylation at H3K4, which
suggests the involvement of epigenetic mechanisms
in this phenomenon. The functional reprogramming
of monocytes, reminiscent of similar NK cell proper-
ties, supports the concept of ‘‘trained immunity’’ and
may be employed for the design of improved vacci-
nation strategies.
INTRODUCTION
It is a general assumption that immunological memory is exclu-
sively mediated by T and B cells. However, protection against
reinfection is present in both plants (Durrant and Dong, 2004)
and insects (Pham et al., 2007; Rodrigues et al., 2010) who
lack specific immunity. Similarly, prototypic mammalian innate
immune cells such as NK cells can build immunological memory,Cell Hosleading to protection against reinfection with viral pathogens
(Cooper et al., 2009; O’Leary et al., 2006; Paust et al., 2010;
Sun et al., 2009). We proposed the term ‘‘trained immunity’’ for
the enhanced state of the innate immune responses following
exposure to certain infectious agents, which may result in an
increased resistance to reinfection (Netea et al., 2011).
Protection from infection in amacrophage-dependent manner
was demonstrated after a previous infection with avirulent
Candida species in mice deficient in T and B cells (Bistoni
et al., 1986), yet the mechanism responsible for this effect
remained unknown. Similarly, b-glucans from C. albicans cell
wall are potent immunomodulators and are used in some coun-
tries for enhancing immunity against infections and cancer
(Brown and Williams, 2009; Vetvicka, 2011).
The aim of the present study was to investigate the ‘‘training’’
effects exerted by C. albicans on monocytes and macrophages,
the cells responsible for the T/B cell-independent protective
effect during secondary Candida infection (Bistoni et al., 1986).
We demonstrate that C. albicans can protect Rag1-deficient
mice from reinfection, an effect that is dependent on the func-
tional reprogramming of monocytes. The mechanism of training
requires the b-glucan receptor dectin-1 and the noncanonical
Raf-1 pathway and is associated with stable and genome-wide
changes in histone methylation, suggesting a putative role of
epigenetic programming as an underlying mechanism.RESULTS
A Nonlethal Candida albicans Infection Induces
Protection from Secondary Lethal Infection through
a T/B Lymphocyte-Independent, Monocyte-Dependent
Mechanism
Preinjection of a low dose of live C. albicans 7 days prior to a
second lethal infection increased the survival rate of wild-type
(WT) mice (Figure 1A). The organ fungal loads and circulatingt & Microbe 12, 223–232, August 16, 2012 ª2012 Elsevier Inc. 223
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Figure 1. Nonlethal Candidiasis Protects Mice through a Macrophage-Dependent Mechanism
(A) Survival rate of WT, Rag1/, and Ccr2/ mice to systemic candidiasis, following vaccination with PBS (control) or a nonlethal dose of live C. albicans
(Candida, preinjection) 7 days earlier (nR 8 per group, two independent experiments).
(B) Fungal burdens in kidneys from Rag1/ mice 14 days after C. albicans infection.
(C) Survival rate of WT mice preinjected with anti-asialo GM1 antibody or an unrelated antibody (control) prior to the inoculation of lethal C. albicans (nR 10 per
group).
(D) In vivo training of mice (n = 5 per group) with heat-inactivated C. albicans (black bars), 7 days prior to the LPS injection, enhanced proinflammatory cytokines
release compared to PBS-treated control mice (white bars). *p < 0.05 versus control animals.
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injection of the low inoculum of Candida (data not shown). The
protection given by preinfection was also conferred to T/B
cell-defective Rag1-deficient mice (Figures 1A and 1B), but not
to monocyte-defective Ccr2-deficient mice (Figure 1A). The
protective effect of Candida preinfection observed in mice
treated with anti-asialo GM1 antibodies (depletion from 7.5%
to 0.6%) was independent of the presence of NK cells (data
not shown). Moreover, mice depleted of NK cells had a better
survival than the mice treated with an unrelated antibody (Fig-
ure 1C), making it highly unlikely that NK cells play an important
role in the protection. These results highlight the importance of
monocytes in the C. albicans-conferred protection.
To assess the effect of monocyte training on cytokine produc-
tion, we investigated the effect ofCandida pretreatment in an en-
dotoxemia model. Induction of cytokines by lipopolysaccharide
(LPS) was enhanced when mice were pretreated 1 week earlier
with low amounts of heat-killed C. albicans (Figure 1D).
Candida albicans Primes the Production of
Proinflammatory Cytokines in Monocytes
Mononuclear phagocytes are the main cell population respon-
sible for proinflammatory cytokine production during infection.224 Cell Host & Microbe 12, 223–232, August 16, 2012 ª2012 ElseviWe assessed whether priming of human peripheral blood mono-
nuclear cells (PBMCs) in vitro with a low dose of C. albicans
would increase the response of cells to a secondary stimulation
(Figure 2A). Preincubation of cells with 104 microorganisms/ml
heat-killed Candida did not induce cytokine production
after 24 hr (data not shown). In contrast, preincubation of cells
with C. albicans increased the concentration of TNF-a and
IL-6 in the supernatant after the secondary stimulation with
C. albicans, as well as with various pattern recognition receptors
(PRRs), ligands, or bacteria (Figure 2B).
To rule out a role for lymphocytes in this effect, we repeated
these experiments with purified monocytes. Exposure of mono-
cytes toCandida for 24 hr primed the production of the proinflam-
matorycytokinesTNF-aand IL-6, but not of theanti-inflammatory
IL-10 (Figure 2C). Cell viability was identical in all conditions
and above 98% (LDH release). Microscopic assessment showed
no remaining intact Candida during the stimulation period.
b-Glucans Enhance the Proinflammatory State
of Monocytes and Prime the Production
of Proinflammatory Cytokines
b-glucans and mannans are major components of the skeletal
cell wall of C. albicans (Netea et al., 2008). The priming effectser Inc.
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Figure 2. Candida albicans and b-Glucans Prime the Production of Proinflammatory Cytokines
(A) Diagram showing the course of the in vitro preincubation experiment.
(B and C) C. albicans training in vitro using freshly isolated human PBMCs (B) or monocytes (C) and different PRR ligands for restimulation (P3C, Pam3ys; C.a,
C. albicans; M.tb, Mycobacteria tuberculosis).
(D) The training effects induced by purified b-glucans (blue), but not with mannans (gray). E. coli preincubation induced immune tolerance (red).
(E) CD14+-selected monocytes are also primed by b-glucan.
(F) The priming effect obtained after 1 week of resting period was also seen after 2 weeks.
(G) Candidacidal activity of cell culture medium (control) or b-glucans-preincubated monocytes was assessed after 5 hr of incubation with live opsonized
C. albicans (n = 6). In (B)–(G), *p < 0.05 (mean ± SD, n = 5–8). See also Figure S1.
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Figure 3. The Role of b-Glucan Receptors for Monocyte Training
(A–D) Cytokine production in supernatants of adherent monocytes primed for 24 hr with either cell culture medium or b-glucans and restimulated with different
PRR ligands in healthy volunteers (control) and cells isolated from a dectin-1-deficient volunteer (A), in the presence or absence of anti-CR3 antibody (B), and in
the presence or absence of Syk kinase inhibitor (C) or Raf-1 inhibitor GW5074 (D).
(E) Survival rate of WT mice to C. albicans infection. All mice were initially treated with a Raf-1 inhibitor. Mice were then preinjected with either PBS (control) or
a nonlethal dose of live C. albicans (Candida, preinjection) 7 days prior to inoculation of the lethal C. albicans dose (nR 10 per group).
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b-glucan, but not with mannans or Toll-like receptor (TLR)
ligands (Figure 2D and data not shown) (Foster et al., 2007).
Similarly, pretreatment of either positively selected CD14+
monocytes or CD4+ T lymphocyte-depleted PBMCs led to
similarly enhanced production of proinflammatory cytokines
(Figure 2E and Figure S1A). In contrast to the monocytes,
pretreatment of CD56+-isolated NK cells with either C. albicans
or b-glucans failed to induce an enhanced production of proin-
flammatory cytokines (data not shown).
While themost robust effect was seen after 24 hr of preincuba-
tion, a priming effect could be detected also when monocytes
were preincubated for shorter periods of time (Figure S1B).
Moreover, preincubation during 24 hr with C. albicans or
b-glucans enabled monocytes to enhance their production of
cytokines for 2 weeks after the training period (Figure 2F and
Figure S1C). Incubation longer than 2 weeks was not achievable
due to declining viability of monocytes thereafter. In addition, the
enhanced production of proinflammatory cytokine by trained
monocytes upon a second stimulation was dose dependent
(Figure S1D). Interestingly, the initial dose of C. albicans and of
b-glucan also influenced the amplitude of the training effect in
a dose-dependent manner (Figure S1E).
In addition, 24 hr preincubation with b-glucans enabled mono-
cytes to enhance their candidacidal activity (Figure 2G) and to
efficiently inhibit the C. albicans outgrowth after 24 hr of culture
(47% ± 9% more inhibition compared to nonprimed control
monocytes).
The Dectin-1/Raf-1 Pathway and the Complement
Receptor 3 Are Required to Induce Training
of Monocytes
The recognition of b-glucan by human cells is dependent on
dectin-1 and complement receptor 3 (CR3) (Netea et al., 2008).
Inhibition of dectin-1 with laminarin inhibited the priming by
b-glucans (Figure S2), and monocytes isolated from a dectin-
1-deficient individual (Ferwerda et al., 2009) could not be effec-
tively trained with b-glucan (Figure 3A). Only a partial inhibition of
the training of monocytes was observed when the CR3 receptor
was blocked (Figure 3B). Dectin-1 activates cellular responses
through the spleen tyrosine kinase and caspase-recruitment
domain protein 9 (Syk/CARD9) (Drummond et al., 2011) and
through the noncanonical serine-threonine kinase Raf-1
pathway (Gringhuis et al., 2009). Incubation of monocytes with
a Raf-1 inhibitor, but not a Syk inhibitor, prior to priming signifi-
cantly reduced the training by b-glucans (Figures 3C and 3D).
Moreover, in vivo inhibition of Raf-1 in mice during the training
abolished the protection conferred by the Candida preinjection
(Figure 3E).(F) Western blot of total and phosphorylated p38 in cells primed with RPMI (con
Pam3Cys.
(G) Quantification of the effect of b-glucan priming on the phosphorylation of p38
(H and I) Fold changes in Tnfa (H) and Il6 (I) mRNA expression obtained by quantita
or C. albicans. Cells were primed with either nutrient-rich medium (RPMI, contro
(J–M) Cytokine production in supernatants of adherent monocytes primed 24 hr w
the absence or presence of the histone demethylase inhibitor pargyline (J and
adenosine) (L and M) and restimulated with different PRR ligands. In (A)–(D) and (
monocytes are presented. Data are shown as mean ± SD. n = 6 for (B), (D), and
experiments. nR 6 for (H) and (I). *p < 0.05. See also Figure S2.
Cell HosMolecular Regulation of Trained Monocytes
Cellular response to extracellular stimuli is mediated through
intracellular signaling cascades such as the p38 MAPK (Zarubin
and Han, 2005). Both the expression of p38 and the p38 phos-
phorylation (i.e., activation) upon TLR2 stimulation were stronger
in the monocytes primed with b-glucan than in the controls
(Figures 3F and 3G). Subsequently, increased gene transcription
of Tnfa and Il6mRNA upon restimulation was observed (Figures
3H and 3I). The long-lasting effect of the b-glucan pretreatment
on gene expression prompted us to investigate whether epige-
netic changes such as histone methylation (Carson et al.,
2011; Foster et al., 2007; Ishii et al., 2009) are associated with
the training of monocytes. Inhibition of histone demethylases
by a specific inhibitor had no effect on the training of monocytes
(Figures 3J and 3K). In contrast, inhibition of histonemethyltrans-
ferases using MTA inhibited monocyte training by C. albicans or
b-glucan (Figures 3L and 3M), supporting the hypothesis that
histone methylation is likely to be involved in the training of
monocytes.
To confirm this hypothesis, we assessed the genome-wide
binding pattern upon b-glucan training of H3K4me3 and
H3K27me3, two histone modifications associated, among
others, with the epigenetic regulation of immune-related genes
(Barski et al., 2007; Buratowski and Kim, 2010; Foster et al.,
2007; Ishii et al., 2009; Mikkelsen et al., 2007; Min et al., 2011;
Sims et al., 2007; Wen et al., 2008). The two independent
genome-wide ChIP-seq data in monocytes showed well-defined
H3K4me3 peaks, while H3K27me3 was present in more diffuse
blocs (Figure S3A) (Martens et al., 2010). A global increase was
seen in H3K4me3 signal in monocytes after b-glucan treatment,
while hardly any changes were observed in H3K27me3 regions
(Figure 4A).
To validate the physiological relevance of the b-glucan-
induced epigenetic modifications observed in vitro, we per-
formed genome-wide ChIP-seq assay for H3K4me3 in peritoneal
macrophages recovered from WT mice 7 days after injection of
either saline (control) or a low dose of C. albicans, showing
a global increase in H3K4me3 signal in macrophages after
C. albicans training (Figure 4B). Genome-wide ChIP-seq data
showed well-defined H3K4me3 peaks (Figures S3B and S3C),
and an increase in H3K4me3 was observed at the level of the
promoter of genes associated with immune signaling pathway
(e.g.,Myd88, Figure S3B), or associated with the training mech-
anism (e.g., Raf-1, Figure S3C).
The H3K4me3 peak regions were ranked on the basis of signal
changes between nontrained control and b-glucan-trained
monocytes in vitro (Figure S3D). We separated 500 peak regions
that showed the highest increase in H3K4me3 occupancy after
b-glucan treatment (Figure S3E) and 500 peak regions thattrols) or b-glucan and subjected to 5, 15, or 30 min stimulation with RPMI or
.
tive real-time PCR in adherentmonocytes after stimulation with LPS, Pam3Cys,
l) or with b-glucan.
ith either cell culture medium or C. albicans (J and L) or b-glucans (K and M) in
K) and the histone methyltransferase inhibitor MTA (50-deoxy-50(methylthio)
J)–(M), the ratios of cytokine production by b-glucan primed versus nonprimed
(J)–(M) and n = 5 for (C). Data presented in (A) are means of two independent
t & Microbe 12, 223–232, August 16, 2012 ª2012 Elsevier Inc. 227
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Figure 4. b-Glucan Alters the Epigenetic Landscape in Trained Monocytes, and This Correlates with b-Glucan-Induced Transcriptomal
Changes
(A) Box plot of log2 tag density of H3K4me3 and H3K27me3 signal in control versus trained monocytes.
(B) Box plot of log2 tag density for genome-wide H3K4me3 enriched regions in peritoneal macrophages retrieved from untreated (control, saline) and Candida
preinjected mice.
(C) Intensity plots showing the normalized tag density for H3K4me3 and H3K27me3 on the 500 H3K4me3 enhanced and decreased regions.
(D–I) Genome browser screen shot showing H3K4me3 binding over TNF-a (D), IL-6 (E), IL-18 (F), DECTIN-1 (G), TLR4 (H), andMYD88 promoter regions (I) before
and after the treatment with b-glucan.
(J) Box plot showing RNA expression (RPKM) of the genes associated with top and bottom 500 regions with H3K4me3 changes.
(K) H3K4me3 tag density as well as RNA-seq expression data over SETD7 histone methyltransferase before and after the treatment with b-glucan.
(L and M) RPKM values of genes after b-glucan treatment of monocytes. The genes are markers of classically and alternatively activated macrophages (L) and of
inflammatory Tip-DCs (M). See also Figure S3.
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Functional Reprogramming of Monocytes by b-Glucansshowed decrease in H3K4me3 levels after treatment (Fig-
ure S3F). The normalized tags’ density in the separated peak
regions revealed significant changes for H3K4me3 levels, with
fewer alterations for H3K27me3 between trained and nontrained
monocytes (Figure 4C). More specifically, H3K4me3 was
elevated at the promoters of important target genes such as
the proinflammatory cytokines TNF-a, IL-6, and IL-18 after
b-glucan treatment (Figures 4D and 4F). Interestingly, b-glucan
treatment of monocytes also upregulated H3K4me3 at the
promoter of DECTIN-1 (3.3-fold, Figure 4G), but also at the
promoters of other C-type lectin receptors and TLRs (Figure 4H).
Finally, training the monocytes with b-glucan increased the
H3K4me3 at the promoter of intracellular signaling molecules,
such as the adaptor molecule MYD88 (Figure 4I).
Additional genome-wide H3K4me3 ChIP-seq were performed
before exposure (day 0) and 24 hr after exposure (day 1) to either
cell culture medium or b-glucan. Hierarchical clustering of the
top and bottom 500 regions with H3K4me3 variations at day 7
(Figure 4C) revealed that many changes noted in day 7 samples
were already apparent after 24 hr of b-glucan incubation (Fig-
ure S3G). This indicates that a stable, b-glucan-induced
epigenetic program could be maintained for at least a week
(Figure S3H).
Transcriptome Changes in Trained Monocytes
Two independent genome-wide RNA-sequencing experiments
revealed global changes in gene expression upon b-glucan
training, with more than 5,800 upregulated and 1,400 downregu-
lated genes (2-fold threshold). Analysis confirmed a strong
correlation between the increase in H3K4me3 occupancy and
the increase in expression (Figure 4J). Importantly, b-glucan
also induced increased gene expression of several histone
methyltransferases after training, including SETD7, which has
been previously related to H3K4me3 (Nishioka et al., 2002)
(Figure 4K).
Activation Markers in Trained Monocytes
Monocytes differentiate into classically activated (M1) or alter-
natively activated (M2) macrophages (Gordon, 2003; Mantovani
et al., 2004). Transcriptome analysis of b-glucan-trained mono-
cytes showed increased RNA level for TNF-a and IL-6 (Figures
3H and 3I) and for TLR2 and TLR4, but less forARG-1 (Figure 4L).
However, the M2 markers MRC1 and CD163 mRNA were also
upregulated in the trained monocytes. Beside macrophages,
monocytes can also differentiate in dendritic cells (DCs) such
as TNF and iNOS producing DCs (Tip-DC) (Aldridge et al.,
2009; Serbina et al., 2003). Except for TLR3, transcriptome anal-
ysis of b-glucan-trained monocytes also showed an increased
RNA level for most of the costimulatory molecules and chemo-
kine receptors associated with Tip-DC phenotypes (Figure 4M).
Thus, b-glucan-trained monocytes display increased activation
markers for M1 and M2 macrophages, as well as for Tip-DC,
arguing against simple skewing of macrophage differentiation
and more likely for a global pan-activation of the cells.
DISCUSSION
The nonspecific adaptive features of innate immunity (Bowdish
et al., 2007) that have been demonstrated in plants, inverte-Cell Hosbrates, and mice and termed ‘‘trained immunity’’ (Netea et al.,
2011) have not been investigated mechanistically in mammalian
cells. In the present study, we demonstrate that monocytes
can be trained to exhibit an enhanced and lasting response to
microbial components after pre-exposure to C. albicans or
b-glucans. This effect was mediated by a dectin-1 receptor/
Raf-1 pathway, leading to more rapid and effective activation
of signaling molecules such as p38. Monocyte training leads to
enhanced gene transcription, which correlates with epigenetic
changes at the level of H3K4me3, but not of H3K27me3, in innate
immunity genes. This combination of signaling and molecular
events leads to enhanced production of proinflammatory cyto-
kines and candidacidal properties.
An important question concerns the molecular mechanism
responsible for monocyte reprogramming. First, signaling
pathways important for inflammation such as p38 activation
are increased (Zarubin and Han, 2005). Second, the trimethyla-
tion profile at the level of H3K4 is enhanced. The combination
of in vivo and in vitro data suggests that these changes may
indeed represent an important component underlying training
of monocytes. This observation is reminiscent of previously
reported epigenetic mechanisms mediating LPS- and TNF-
induced tolerance (Foster et al., 2007). Additionally, chromatin
remodeling has been shown to be a key mechanism in the
regulation of the polarization toward classically and alternatively
activated macrophage subtypes (Ishii et al., 2009; Takeuch and
Akira, 2011).
The identification of adaptive features for the innate immune
responses induced in mononuclear phagocytes has important
conceptual and practical consequences. Recently, NK cells,
another prototypical type of innate immune cells, have been
demonstrated to possess memory characteristics (O’Leary
et al., 2006; Paust et al., 2010; Sun et al., 2009). The observation
that NK cells and mononuclear phagocytes share properties
of nonspecific immunological memory (or can be ‘‘trained’’)
strongly suggests that these features are a fundamental compo-
nent of host defense (Netea et al., 2011). At this moment we have
little information on the duration of the protection that can be
provided by trained immunity, even though epigenetic modifica-
tions have been reported to correlate with long-term maintained
mechanisms (Margueron et al., 2005; Wen et al., 2008). The
conferred protection might be quite long, as epidemiologic
studies in children have shown that BCG vaccination exerts
nonspecific protection of children from nonmycobacterial infec-
tions for at least the duration of early childhood (Garly et al.,
2003; Rosenthal et al., 1961). If demonstrated to be long-lived,
it is to be expected that trained immunity will have important
consequences for the design of vaccination strategies that
may exploit both trained immunity and classical T/B lympho-
cyte-immunological memory.
One may also speculate about the evolutionary aspects of
Candida-induced trained immunity. The observation that
C. albicans can prime and enhance the proinflammatory immune
response of monocytes may represent a possible reason why
C. albicans became a commensal in humans (Pfaller and Die-
kema, 2007). It is tempting to hypothesize that C. albicans not
only colonizes, but also trains innate immune cells at mucosal
barriers, thereby providing enhanced immune control at the
sites where the host is most often in contact with potentiallyt & Microbe 12, 223–232, August 16, 2012 ª2012 Elsevier Inc. 229
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response might be harmful in individuals with genetic predispo-
sitions for autoimmune or autoinflammatory conditions such as
Crohn’s disease. In this respect, it is interesting to observe that
Crohn’s disease is characterized by the presence of specific
anti-Candida antibodies (McKenzie et al., 1990; Sutton et al.,
2000).
In conclusion, in the present study we demonstrate that
C. albicans, and b-glucans in particular, induce epigenetic re-
programming of monocytes through a dectin-1/Raf-1 pathway,
resulting in enhanced cytokine production. The epigenetic
modulation of innate immune responses is likely to represent
an important characteristic of the protection against reinfection
conferred by what it has been recently described as ‘‘trained
immunity.’’
EXPERIMENTAL PROCEDURES
Animals
C57BL/6J, B6.129S7-Rag1tm1Mom/J, and B6.129S4-Ccr2tm1lfc/J female mice
(8–12 weeks) were used (Jackson Laboratories). Experiments were approved
by the Ethics Committee on Animal Experiments of the University of Athens.
Mice were injected with live C. albicans blastoconidia (2 3 104 cfu/mouse)
or pyrogen-free phosphate-buffered saline (PBS) alone. Seven days later,
mice were infected intravenously with a lethal dose of live C. albicans (2 3
106 cfu/mouse). Survival was monitored and kidney fungal burden assessed
on day 14. Raf-1 activation was inhibited by 25 mg/kg Sorafenib orally admin-
istered 7 days before and on the day of the low dose of C. albicans blastoco-
nidia injection. In the endotoxemia model, mice were injected intravenously
with heat-inactivated C. albicans blastoconidia (1 3 105 cfu/mouse) or PBS
alone and 7 days later with an intraperitoneal dose of 10 mg purified LPS
(E. coli serotype 055:B5, Sigma-Aldrich). Blood was collected 90 min later
to assess the circulating TNF-a and IL-6 concentrations.
Healthy Volunteers
PBMCs were isolated from buffy coats obtained from healthy volunteers
(Sanquin Bloodbank, Nijmegen, the Netherlands).
Reagents
Ficoll-Paque (GE Healthcare) was used to isolate PBMCs by differential centri-
fugation. CD14+ monocytes, CD56+ NK cells, and CD4 subsets were purified
using MACS isolation.
Candida albicans mannans and b-1,3-(D)-glucan (b-glucan) were kindly
provided by Professor David Williams. Reagents used were as follows:
Pam3Cys (EMCmicrocollections, L2000), LPS (Sigma-Aldrich, E. coli serotype
055:B5), Laminarin (Sigma-Aldrich, L-9634), a-CR3 (R&D, AF 1730), isotype
control goat IgG (R&D, AB-108-c), Syk inhibitor (EMD, 574711), Raf-1 inhibitor
(GW5074, Sigma-Aldrich, 6416), histone demethylase inhibitor Pargyline
(Sigma-Aldrich, P8013), and histone methyltransferase inhibitor (MTA,
Sigma-Aldrich, D5011).
Microorganisms
C. albicans ATCC MYA-3573 (UC 820) and E. coli strain ATCC35218 were
heat-inactivated for 30 min at 95C. M. tuberculosis H37Rv suspensions
were sonicated for 10 min on ice.
Stimulation Experiments
PBMCs (53 105 cells) were incubated for 1 hr at 37C in 5%CO2 and adherent
monocytes were selected by washing out nonadherent cells with warm PBS.
CD14+-purified monocytes were diluted to a concentration of 1 3 105/100 ml.
For training, cells were preincubated with heat-killed C. albicans (1 3 104/ml),
b-glucan (10 mg/ml), mannans (10 mg/ml), or E. coli (1 3 106/ml) for 24 hr.
After 7 days cells were stimulated with various stimuli: LPS, 10 ng/ml;
Pam3Cys, 10 mg/ml; heat-killed C. albicans, 1 3 105/ml; M. tuberculosis,
1 mg/ml. After 24 hr, supernatants were collected and stored at 20C.230 Cell Host & Microbe 12, 223–232, August 16, 2012 ª2012 ElseviFor inhibition, before priming with C. albicans or with b-glucan, monocytes
were preincubated for 1 hr with laminarin (dectin-1 inhibitor, 100 mg/ml),
anti-CD3 antibody and control anti-IgG (10 mg/ml), Syk inhibitor (50 nM),
Raf-1 inhibitor (1 mM), Pargyline (3 mM), and MTA (1 mM). TNF-a, IL-6, and
IL-10 were measured using ELISA (IL-6, IL-10: Sanquin; TNF-a: R&D).
Quantitative RT-PCR
Isolated RNA was reverse-transcribed into complementary DNA using iScript
cDNA Synthesis Kit (Bio-Rad), and quantitative PCR was performed as
described in the Supplemental Information.
Chromatin Immunoprecipitation
For chromatin immunoprecipitation (ChIP), adherent monocytes were cultured
as described in the Supplemental Information. For the mouse samples, mice
were injected intraperitoneally with either PBS or 5 3 103 C. albicans 7 days
prior the collection of the peritoneal macrophages. ChIP was performed using
antibodies against H3K4me3 (Diagenode) and H3K27me3 (Millipore). ChIPed
DNA was further processed for high-throughput sequencing using Illumina
Genome Analyzer II as described before (Martens et al., 2010). High-quality
sequenced reads were uniquely mapped to human hg18 and mouse mm9
using ELAND.
For H3K4me3 data sets, peaks were called using ‘‘Genomatix’’ tool NGS
from RegionMiner ChIP-seq workflow. Individual peaks within 500 bp region
were further merged. For H3K27me3 enriched blocs, peaks were called as
previously described (Pauler et al., 2009). Biological replicates were produced
for all conditions. For the differential, regions tags were counted in merged
peak file from both trained and nontrained (RPMI control) monocytes and to
rank peaks as a function of the magnitude of change, the difference for each
peak in fractional tag count between control and trained condition was divided
by the difference between 1 and their sum (fT  fC)/(1  fT  fC).
Genome Annotation
Genes were annotated for the top 500 increased and 500 decreased regions
in H3K4me3 (http://pinkthing.cmbi.ru.nl/cgi-bin/index52.pl).
RNA-Seq
RNA was processed as described in Supplemental Information. Briefly,
double-stranded cDNA were used for Illumina sample prepping and
sequenced. RNA-seq reads were uniquely mapped to hg18 and used for bio-
informatic analysis. RPKM (reads per kilobase of gene length per million reads)
values for RefSeq genes were computed using tag counting scripts and used
to analyze the expression level of the genes in nontreated (RPMI) and
b-glucan-trained monocytes. Biological replicates were sequenced and pro-
cessed in the same manner.
Western Blots
For western blotting of p38 MAPK (total and phosphorylated), training was
performed as described in stimulation experiments. A detailed western blot
methodology is described in Supplemental Information.
Candidacidal Activity
Priming of the cells was performed in 96-well plates as described. A total of
13 104 opsonizedC. albicans (see Supplemental Information) were incubated
together with RPMI-primed monocytes, b-glucan-primed monocytes, or no
cells (control well) for 5 and 24 hr at 37C. After the incubation time, the content
of each well was recovered in sterile water, serially diluted, and plated on
Sabouraud plates. After 24 hr at 29C, the cfu were counted. The candidacidal
activity was calculated as a ratio of Candida growth in RPMI- or b-glucan-
primed cells versus control wells (Candida alone, no cells).
Statistical Analysis
The differences between groups were analyzed using the Wilcoxon signed-
rank test (unless otherwise stated). Statistical significance of survival experi-
ment was calculated using the product limit method of Kaplan and Meier.
The level of significance was defined as a p value of < 0.05.er Inc.
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Data are available through the GEO database (GSE34260).
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.chom.2012.06.006.
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